Investment
Features
FeesSafety
Academy
More
Pluang+

Goldman Sachs S&P 500 Premium Income ETF (GPIX) rated BUY with 7%-10% return target and 8% yield for income investors.

Analyst Insights
17 Aug 2026
Seeking Alpha
View Source
Bullish
pluang ai news

The Goldman Sachs S&P 500 Premium Income ETF (GPIX) has received a BUY rating, aiming for a total return of 7%-10% over the next 6-12 months. This fund offers an attractive 8% yield while closely tracking the S&P 500 index, making it appealing for investors focused on income without sacrificing much market return. Its dynamic call overwrite strategy and tech-heavy portfolio have achieved a 90.5% upside capture with lower volatility compared to the S&P 500. As GPIX is near its 52-week high, future gains are expected mainly from distributions and modest market appreciation rather than sharp price rallies.

More News

Bitfinex lists five tokenized bitcoin treasury company notes for trading in dollars, Tether, and bitcoin.

Bitfinex lists five tokenized bitcoin treasury company notes for trading in dollars, Tether, and bitcoin.

Bitfinex Securities has listed five tokenized notes representing shares in bitcoin treasury companies Strategy, Metaplanet, H100 Group, and Capital B, plus a preferred stock note from Strategy. These notes, issued via a Luxembourg fund and traded on ...

Market News
Bullish
4 hours ago
Alumis stock plunges 57% after lupus drug trial fails, but psoriasis drug progress continues.

Alumis stock plunges 57% after lupus drug trial fails, but psoriasis drug progress continues.

Alumis' stock dropped 56.58% after its Phase II lupus drug trial failed to meet main goals, causing a significant market reaction. However, positive results in a subgroup of lupus patients with a high interferon gene signature offer a potential path ...

Market News
Bearish
4 hours ago
Zepp Health Q2 2026 revenue rises 6.9% but posts $11.3M net loss amid higher costs and investments

Zepp Health Q2 2026 revenue rises 6.9% but posts $11.3M net loss amid higher costs and investments

Zepp Health reported Q2 2026 revenue of $63.5M, up 6.9% year-over-year, driven by new product launches and improved product mix. Gross margin improved to 37.4%, but net loss widened to $11.3M due to foreign exchange headwinds and increased spending o...

Company Fundamentals
Neutral
4 hours ago
Alumis plunges 57% after trial failure; Enovis falls 16% on robotics acquisition news

Alumis plunges 57% after trial failure; Enovis falls 16% on robotics acquisition news

Alumis Inc. shares dropped 56.76% after its Phase 2b trial for a lupus drug failed to meet key goals, though some patient groups showed promise. Enovis Corporation shares fell 16.51% following its announcement to acquire eCential Robotics for €155 mi...

Market News
Bearish
4 hours ago
SPACs, biotech, geothermal, and AI stocks rally with major deals and volatility driving gains

SPACs, biotech, geothermal, and AI stocks rally with major deals and volatility driving gains

SPAC stocks like Rising Dragon Acquisition surged nearly 47% amid volatility, while biotech firm bioAffinity Technologies jumped 44% after a reverse stock split. Renewable energy company Fervo Energy gained 28% following a major geothermal power deal...

Market News
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App